Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid.
We have used proteomic fingerprinting to investigate diagnosis of Alzheimer's disease (AD). Samples of lumbar cerebrospinal fluid (CSF) from clinically-diagnosed AD cases (n = 33), age-matched controls (n = 20), and mild cognitive impairment (MCI) patients (n = 10) were used to obtain proteomic...
Huvudupphovsmän: | Vafadar-Isfahani, B, Ball, G, Coveney, C, Lemetre, C, Boocock, D, Minthon, L, Hansson, O, Miles, A, Janciauskiene, S, Warden, D, Smith, A, Wilcock, G, Kalsheker, N, Rees, R, Matharoo-Ball, B, Morgan, K |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2012
|
Liknande verk
Liknande verk
-
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease
av: Ahmad, S, et al.
Publicerad: (2020) -
Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
av: Chapel, H, et al.
Publicerad: (1984) -
Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid
av: Richens, J, et al.
Publicerad: (2014) -
Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathy.
av: Esiri, M, et al.
Publicerad: (1985) -
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
av: Appleyard, M, et al.
Publicerad: (1987)